Deck Antares Consulting

Transcript

2. provides effective specific mobile tools for enabling chronic patients an active role in the management of their disease.
3. why? • Societies are ageing. • Chronic patients are a 20% who generates the 70% of the healthcare costs. • Evidence indicates that chronicity must be managed at home; being better for the chronics and better for the system. HEALTH CARE FOR CHRONIC IS GOING MOBILE HEALTH
4. NO PATIENTS lack of adherence; do not have incentives, outcomes DOCTORS do not have workload benefits, do not trust in no scientific base apps and real outcomes. 40.000 apps, only 5% used IS HAPPENING?
5. solution Medical Devices sensors + management app
6. Specific metrics for each chronic type •Certified Medical Devices, developed by doctors and clinically tested. •Beyond commoditie data without specificity, beyond wellness. •Personal vital signs tracking and management.
7. Adapted to the age profile of most part of chronics. •Wearables, Minimal patient action, easy to use, multiplatform. •Clear final message. •Optional caregiver involvement.
8. In-app educational materials for motivation •Promoting patient became a “expert patient”. •Promoting of actions and change of behaviours.
9. for pacemaker recipients access to information about the integrity of the pacemaker, any time, anywhere
10. PARTNERS
11. Ageing Increase of detection Global PACEMAKERS RECIPIENTS MARKET
12. PATIENT PROFILE 76 AVERAGE AGE SOURCE http://www.pacemakerclub.com/public/jpage/1/p/Home/content.do +70%
14. Electrocardiography (ECG II & III) Heart Rate Respiratory Rate Body Surface Temperature Accelerometer data Heart Rate Recovery Sleep Analysis Heart Rate Variability Physical Activity Level Body Position & Motion Battery status Stimulation mode Leads insulation integrity Breakage of the electrodes Dislocation of the electrodes TECHNOLOGY MEASURES UNIVERSAL INDIRECT OUTPUT
15. device data available to Caregivers analysis data available to •Physical Data •Pacemaker Integrity Data •Arrhythmia report •Predictive and diagnostic reports FREEMIUN AREA PREMIUN AREA
16. The objective is to achieve patients use on regular basis the “device integrity” feature, allowing backend ECG data analysis for: • Detection of arrythmias and its classification • Detection of specifc disfunctions relationed with PM functioning • Automatized risk prediction of hearth diseases like Suden Cardiac Death, Hearth failure or Miocardial damage. VALUE PROPOSAL
18. • Algorithm Proof of concept developed • NEXT: Prototyping HW/SW requirements Product Status • Algorithm for battery status, lead integrity and dislocation, already developed. • NEXT: Arrhythmia, Isquemia and Suddden Cardiac Death algorythm development Backend Status
19. BUSSINES MODEL
20. B2B Wellness Health B2C Medical device space
21. NICHE
22. NEXT DEVELOPMENTS • Congestive Hearth Failure Mobile tool • Prevent reentry Metric • Fluid accumulation Monitoring
23. COMPETITORS
24. RECENT ADQUISITIONS Acquired in 2014 by Covidien for 138 $M Acquired in 2014 by Airstrip Acquired in 2014 by Medtronic for 150 $M
25. Equipo Samuel Borreguero Dirección de Proyectos Desarrollo de Negocio Ana Belén González Dirección Técnica y Financiera Ignacio Núñez Dirección Comercial y Marketing Dr. Jaime del Barrio D. General Instituto Roche Dr. Julian Pérez Villacastín D. Unidad de Arritmias Hospital Clínico San Carlos Assesors Founders
26. Partners Scientific Partners Financial Partners
27. RONDAS DE FINANCIACIÓN Date Investor Amount (€) Marzo 2014 CDTI 250.000 1ª SEED ROUND Abril 2014 AGENCIA IDEA 85.000 Abril 2014 CAIXA CAPITAL RISC 50.000 Achivements How much and for what? 330.000 € PROTOTYPING CE CERTIFICATE CLINICAL TEST PRE MARKET ACTIVITY 385.000 € IDEA , VALIDATION , B. PLAN PROOF OF CONCEPT PRE PROTOTYPE PROTOTYPING CLINICAL TESTING MARKET 2.013 2.015 2.016 Current Status 2.014
28. www.talemnology.com founders@talemnology.com @talemnology 670.54.06.70